169 related articles for article (PubMed ID: 37699495)
1. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
He YZ; Wang YX; Ma JS; Li RN; Wang J; Lian TY; Zhou YP; Yang HP; Sun K; Jing ZC
Vascul Pharmacol; 2023 Dec; 153():107216. PubMed ID: 37699495
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.
Siregar FM; Hartopo AB; Haryana SM
Narra J; 2024 Apr; 4(1):e579. PubMed ID: 38798867
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA in pulmonary vascular disease.
Rothman AM; Chico TJ; Lawrie A
Prog Mol Biol Transl Sci; 2014; 124():43-63. PubMed ID: 24751426
[TBL] [Abstract][Full Text] [Related]
6. miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism.
Sun L; Lin P; Chen Y; Yu H; Ren S; Wang J; Zhao L; Du G
Theranostics; 2020; 10(12):5581-5599. PubMed ID: 32373233
[No Abstract] [Full Text] [Related]
7. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
Ma C; Xu Q; Huang S; Song J; Sun M; Zhang J; Chu G; Zhang B; Bai Y; Zhao X; Wang Z; Li P
FASEB J; 2023 May; 37(5):e22906. PubMed ID: 37052859
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
[TBL] [Abstract][Full Text] [Related]
9. Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
Thompson AAR; Lawrie A
Trends Mol Med; 2017 Jan; 23(1):31-45. PubMed ID: 27989641
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
[TBL] [Abstract][Full Text] [Related]
11. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
[TBL] [Abstract][Full Text] [Related]
12. microRNA and Pulmonary Hypertension.
Boucherat O; Potus F; Bonnet S
Adv Exp Med Biol; 2015; 888():237-52. PubMed ID: 26663186
[TBL] [Abstract][Full Text] [Related]
13.
Peng Y; Dai J; Zhao YY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of microRNAs in pulmonary arterial hypertension.
Lee A; McLean D; Choi J; Kang H; Chang W; Kim J
BMB Rep; 2014 Jun; 47(6):311-7. PubMed ID: 24755557
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in pulmonary arterial hypertension.
Zhou G; Chen T; Raj JU
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):139-51. PubMed ID: 25192340
[TBL] [Abstract][Full Text] [Related]
17. Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension.
Miao C; Chang J; Zhang G
Mol Biol Rep; 2018 Dec; 45(6):2883-2896. PubMed ID: 30298350
[TBL] [Abstract][Full Text] [Related]
18. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.
Wu D; Talbot CC; Liu Q; Jing ZC; Damico RL; Tuder R; Barnes KC; Hassoun PM; Gao L
J Mol Med (Berl); 2016 Aug; 94(8):875-85. PubMed ID: 27188753
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership.
Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX
Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036
[TBL] [Abstract][Full Text] [Related]
20. Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
Han Y; Ali MK; Dua K; Spiekerkoetter E; Mao Y
Cells; 2021 Jul; 10(8):. PubMed ID: 34440661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
